Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia

Rheumatology

Volumn 49, Issue 9, 2010, Pages 1776-1782

  Herrick, Ariane L ^a   Moore, Tonia L ^b   Murray, Andrea K ^a   Whidby, Nina ^a   Manning, Joanne B ^b   Bhushan, Monica ^b   Vail, Andy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti centromere antibody; Digital ischaemia; Nail fold capillaroscopy; Systemic sclerosis; Telangiectases

Indexed keywords

CENTROMERE ANTIBODY; PROSTANOID; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CALCINOSIS; CAPILLAROSCOPY; CAPILLARY; CLINICAL FEATURE; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NAIL BED; NAIL FOLD CAPILLAROSCOPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOKING; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; CENTROMERE; FEMALE; FINGERS; HUMANS; ISCHEMIA; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TELANGIECTASIS; YOUNG ADULT;

EID: 77955729149     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq139     Document Type: Article

References (25)

1. Campbell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975;4:351-68.
2. Herrick AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527-33.
3. Maricq HR, Weinberger AB, LeRoy EC. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy. J Rheumatol 1982;9:289-91.
4. Carpentier PH, Maricq HR. Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 1990;16:75-91.
5. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003;48:3023-30.
6. Bukhari M, Herrick AL, Moore T, Manning J, Jayson MIV. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996;35:1127-31.
7. Bukhari M, Hollis S, Moore T, Jayson MIV, Herrick AL. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 2000;39: 506-12.
8. Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL. Computerised nailfold video capillaroscopy - a new tool for the assessment of Raynaud's phenomenon. J Rheumatol 2005;32:841-8.
9. Moore TL, Vail A, Herrick AL. Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon. Rheumatology 2007;46:363-4.
10. Murray AK, Feng K, Moore TL, Allen PD, Taylor CJ, Herrick AL. Automated nailfold capillaroscopy - a time-saving advance in the assessment of scleroderma spectrum disorders [Abstract]. Rheumatology 2008; 47(Suppl. 2):ii22.
11. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976;61:862-70.
12. Hofstee HMA, Noordegraaf AV, Voskuyl AE et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009;68:191-5.
13. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998;15:202-5.
14. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1992;35:688-93.
15. Herrick AL, Heaney M, Hollis S, Jayson MIV. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 1994;53:540-2.
16. Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz JP. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis Does diltiazem induce its regression? Ann Rheum Dis 1998;57:252-4.
17. Sebastiani M, Manfredi A, Colaci M et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009;61:688-94.
18. Steen VD, Zeigler GL, Rodnan GP et al. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984;27:125-31.
19. Braverman IM, Ken-Yen A. Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. J Invest Dermatol 1983;81: 489-97.
20. Clark S, Campbell F, Moore T, Jayson MI, King TA, Herrick AL. Laser Doppler imaging - a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis. Microvasc Res 1999;57:284-91.
21. Korn JH, Mayes M, Matucci Cerinic M et al. for the RAPIDS-1 Study Group. Digital ulcers in systemic sclerosis. Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50: 3985-93.
22. Cutolo M, Pizzorni C, Tuccio M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26.
23. De Angelis R, Cutolo M, Salaffil F, Pablo Restrepo J, Grassi W. Quantitative and qualitative assessment of one rheumatology trainee's experience with a self-teaching programme in videocapillaroscopy. Clin Exp Rheumatol 2009;27:651-3.
24. Houtman PM, Kallenberg CG, Fidler V, Wouda AA. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease. J Rheumatol 1986;13:556-63.
25. Murray AK, Moore TL, Manning JB, Taylor C, Griffiths CEM, Herrick AL. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthritis Care Res 2009;61:1103-11.